Aquaporins: Important players in the cardiovascular pathophysiology.

AER-271 (PubChem CID:10412080) Aquaporin Bacopaside(PubChem CID:21599442) Bumetanide (PubChem CID:2471) Cardiovascular system Chemical compounds studied in this article Acetazolamide (PubChem CID:1986) HAuCl4 (PubChem CID:10925836) LiCl (PubChem CID: 433294) Localization Methylene blue (PubChem CID:6099) Modulators Pathophysiology Phloretin (PubChem CID:4788) Quercetin (PubChem CID:5280459) TGN-020 (PubChem CID:4173511)

Journal

Pharmacological research
ISSN: 1096-1186
Titre abrégé: Pharmacol Res
Pays: Netherlands
ID NLM: 8907422

Informations de publication

Date de publication:
09 2022
Historique:
received: 06 05 2022
revised: 20 07 2022
accepted: 22 07 2022
pubmed: 30 7 2022
medline: 14 9 2022
entrez: 29 7 2022
Statut: ppublish

Résumé

Aquaporin is a membrane channel protein widely expressed in body tissues, which can control the input and output of water in cells. AQPs are differentially expressed in different cardiovascular tissues and participate in water transmembrane transport, cell migration, metabolism, inflammatory response, etc. The aberrant expression of AQPs highly correlates with the onset of ischemic heart disease, myocardial ischemia-reperfusion injury, heart failure, etc. Despite much attention to the regulatory role of AQPs in the cardiovascular system, the translation of AQPs into clinical application still faces many challenges, including clarification of the localization of AQPs in the cardiovascular system and mechanisms mediating cardiovascular pathophysiology, as well as the development of cardiovascular-specific AQPs modulators.Therefore, in this study, we comprehensively reviewed the critical roles of AQP family proteins in maintaining cardiovascular homeostasis and described the underlying mechanisms by which AQPs mediated the outcomes of cardiovascular diseases. Meanwhile, AQPs serve as important therapeutic targets, which provide a wide range of opportunities to investigate the mechanisms of cardiovascular diseases and the treatment of those diseases.

Identifiants

pubmed: 35905892
pii: S1043-6618(22)00308-5
doi: 10.1016/j.phrs.2022.106363
pii:
doi:

Substances chimiques

Aquaporins 0
Water 059QF0KO0R

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106363

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Zhang Shangzu (Z)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Xie Dingxiong (X)

Gansu Institute of Cardiovascular Diseases, LanZhou,China.

Ma ChengJun (M)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Chen Yan (C)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Li Yangyang (L)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Liu Zhiwei (L)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Zhou Ting (Z)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Miao Zhiming (M)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Zhang Yiming (Z)

Gansu University of traditional Chinese Medicine, LanZhou, China.

Zhang Liying (Z)

Gansu University of traditional Chinese Medicine, LanZhou, China; Gansu Institute of Cardiovascular Diseases, LanZhou,China. Electronic address: zhangliying201212@163.com.

Liu Yongqi (L)

Gansu University of traditional Chinese Medicine, LanZhou, China; Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and Universities Gansu University of Chinese Medicine, Lanzhou, China; Key Laboratory of Dunhuang Medicine and Transformation at Provincial and Ministerial Level, Lanzhou, China. Electronic address: liuyongqi73@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH